tiprankstipranks
Trending News
More News >
Hyloris Pharmaceuticals SA (DE:52U)
FRANKFURT:52U
Germany Market
Advertisement

Hyloris Pharmaceuticals SA (52U) Financial Statements

Compare
6 Followers

Hyloris Pharmaceuticals SA Financial Overview

Hyloris Pharmaceuticals SA's market cap is currently €163.52M. The company's EPS TTM is €-0.127; its P/E ratio is ―; Hyloris Pharmaceuticals SA is scheduled to report earnings on September 25, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Currency in EUR

Hyloris Pharmaceuticals SA Earnings and Revenue History

Hyloris Pharmaceuticals SA Debt to Assets

Hyloris Pharmaceuticals SA Cash Flow

Hyloris Pharmaceuticals SA Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis